Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 18, Issue 10, pp. 1822-1831
PubMed
Published By
Print ISSN
Online ISSN
History
- Received January 31, 2019
- Revision received June 19, 2019
- Accepted July 30, 2019
- Published first August 8, 2019.
Article Versions
- Previous version (August 8, 2019 - 06:06).
- Previous version (September 11, 2019 - 08:10).
- You are viewing the most recent version of this article.
Copyright & Usage
©2019 American Association for Cancer Research.
Author Information
- Mario I. Vega1,
- Yijiang Shi1,
- Patrick Frost1,
- Sara Huerta-Yepez2,3,
- Gabriela Antonio-Andres2,3,
- Rogelio Hernandez-Pando4,
- Jihye Lee5,
- Michael E. Jung6,7,
- Joseph F. Gera1,7, and
- Alan Lichtenstein1,7,*
- 1Hematology-Oncology, VA West LA-UCLA Medical Center, Los Angeles, California.
- 2Hospital Infantil de Mexico Federico Gomez, Mexico City, Mexico.
- 3Pathology & Laboratory Medicine, UCLA Medical School, Los Angeles, California.
- 4Patologia Experimental, Instituto Nacional de Ciencas Medicas, CDMX, Mexico.
- 5Gachon University, Incheon, Korea.
- 6Department of Chemistry & Biochemistry, University of California, Los Angeles, California.
- 7Jonsson Cancer Center, University of California, Los Angeles, California.
- ↵*Corresponding Author:
Alan Lichtenstein, University of California Los Angeles, 11301 Wilshire Blvd, Bldg 304, Room E1-115, Los Angeles, CA 90073. Phone 310-478-3711, ext. 40021; Fax: 310-268-4508; E-mail: alan.lichtenstein{at}med.va.gov
October 2019
Volume 18, Issue 10
Volume 18, Issue 10
A Novel Therapeutic Induces DEPTOR Degradation in Multiple Myeloma Cells with Resulting Tumor Cytotoxicity
Jump to section
Advertisement